Study number 8539-173
Dates
Feb 24 2026-Mar 02 2026
Location
Madison, Wisconsin
Age
18-45
Gender
Females
Smoker
No
Compensation
$3,125
Group
C1
This study drug is a penicillin class antibiotic that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infection (UTIs) caused by certain types of bacteria.
Madison, WI is now recruiting Women Currently Breastfeeding, ages 18-45
Refer a friend & receive $500 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
C1
Check-in: Feb 24
Check-out: Feb 26
Follow-up call: Mar 2